Zoetis Inc. financial data

Symbol
ZTS on NYSE
Industry
Pharmaceutical Preparations
Location
10 Sylvan Way, Parsippany, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 349 % +28%
Quick Ratio 145 % +41.9%
Debt-to-equity 183 % -12.1%
Return On Equity 46.7 % -4.11%
Return On Assets 16.5 % +4.44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 453M shares -1.58%
Common Stock, Shares, Outstanding 454M shares -1.51%
Entity Public Float 79.3B USD -1.5%
Common Stock, Value, Issued 5M USD 0%
Weighted Average Number of Shares Outstanding, Basic 456M shares -1.39%
Weighted Average Number of Shares Outstanding, Diluted 456M shares -1.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.92B USD +8.43%
Nonoperating Income (Expense) -15M USD -112%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.89B USD +2.33%
Income Tax Expense (Benefit) 552M USD -10.8%
Net Income (Loss) Attributable to Parent 2.34B USD +5.92%
Earnings Per Share, Basic 5.12 USD/shares +7.56%
Earnings Per Share, Diluted 5.11 USD/shares +7.58%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.57B USD -8.33%
Accounts Receivable, after Allowance for Credit Loss, Current 1.38B USD +4.61%
Inventory, Net 2.45B USD -9.22%
Other Assets, Current 467M USD +5.42%
Assets, Current 6.2B USD +0.31%
Deferred Income Tax Assets, Net 366M USD +90.6%
Property, Plant and Equipment, Net 3.2B USD +6.28%
Operating Lease, Right-of-Use Asset 222M USD -0.89%
Intangible Assets, Net (Excluding Goodwill) 1.23B USD -2.08%
Goodwill 2.74B USD +0.92%
Other Assets, Noncurrent 210M USD +21.4%
Assets 14.2B USD +3.03%
Accounts Payable, Current 420M USD -9.48%
Employee-related Liabilities, Current 276M USD +11.7%
Accrued Liabilities, Current 683M USD +0.15%
Liabilities, Current 1.8B USD +1.58%
Accrued Income Taxes, Noncurrent 267M USD -3.96%
Deferred Income Tax Liabilities, Net 175M USD +44.6%
Operating Lease, Liability, Noncurrent 181M USD -3.72%
Other Liabilities, Noncurrent 222M USD +2.3%
Liabilities 9.21B USD +0.84%
Accumulated Other Comprehensive Income (Loss), Net of Tax -845M USD +5.59%
Retained Earnings (Accumulated Deficit) 11.1B USD +16.6%
Stockholders' Equity Attributable to Parent 4.97B USD +7.37%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.96B USD +7.34%
Liabilities and Equity 14.2B USD +3.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 595M USD +8.38%
Net Cash Provided by (Used in) Financing Activities -524M USD +70.9%
Net Cash Provided by (Used in) Investing Activities -131M USD +39.4%
Common Stock, Shares Authorized 6B shares 0%
Common Stock, Shares, Issued 502M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -66M USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.57B USD -8.33%
Interest Paid, Excluding Capitalized Interest, Operating Activities 68M USD -23.6%
Deferred Tax Assets, Valuation Allowance 131M USD +1.55%
Operating Lease, Liability 236M USD +3.06%
Payments to Acquire Property, Plant, and Equipment 140M USD -37.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.39B USD +17.4%
Lessee, Operating Lease, Liability, to be Paid 271M USD -3.21%
Property, Plant and Equipment, Gross 5.8B USD +14.8%
Operating Lease, Liability, Current 48M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48M USD +6.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 57M USD +9.62%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +36%
Deferred Income Tax Expense (Benefit) -43M USD -638%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35M USD -31.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38M USD +2.7%
Deferred Tax Assets, Operating Loss Carryforwards 133M USD +18.8%
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 214M USD -1.38%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30M USD -3.23%
Operating Lease, Payments 15M USD +7.14%
Additional Paid in Capital 1.15B USD +4.37%
Amortization of Intangible Assets 176M USD -6.88%
Depreciation, Depletion and Amortization 503M USD +5.9%
Deferred Tax Assets, Net of Valuation Allowance 366M USD +90.6%
Share-based Payment Arrangement, Expense 19M USD +11.8%
Interest Expense 235M USD -0.42%